Literature DB >> 19697035

Differential effect of IL-1β and TNFα on the production of IL-6, IL-8 and PGE2 in fibroblast-like synoviocytes and THP-1 macrophages.

Hyun Mi Choi1, Da Hee Oh, Jun Soo Bang, Hyung-In Yang, Myung Chul Yoo, Kyoung Soo Kim.   

Abstract

Inflammation in the joint of rheumatoid arthritis is a complex immune reaction facilitated by various factors, such as cytokines, cells and hypoxia. Thus, we evaluated their relative capacity to produce proinflammatory mediators in response to IL-1beta, TNF-alpha or IL-17 under hypoxia or normoxia in fibroblast-like synoviocytes (FLSs) and macrophages. The level of IL-6 expression was strongly increased in both FLSs and THP-1 macrophages in response to IL-1beta and TNF-alpha, but the level by TNF-alpha was less than that by IL-1beta. In contrast, the expression of IL-8 in both cell types was strongly stimulated by both IL-1beta and TNF-alpha. In FLSs, PGE(2) production increased only in response to IL-1beta; and no effect was observed in THP-1 cells and TNF-alpha-stimulated FLSs. In addition, the production by IL-17 was extremely low when compared with those induced by IL-1beta or TNF-alpha in FLSs and THP-1 cells. Hypoxia (2% O(2)) decreased IL-1beta-stimulated production of PGE(2), even though it increased the expression of mRNA and protein of COX-2. These results suggest that IL-1beta and TNF-alpha differentially regulate gene expression in FLSs and macrophages under hypoxia or normoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19697035     DOI: 10.1007/s00296-009-1089-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts.

Authors:  B Berse; J A Hunt; R J Diegel; P Morganelli; K Yeo; F Brown; R A Fava
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  TNF alpha and IL-1 beta are separate targets in chronic arthritis.

Authors:  W B van den Berg; L A Joosten; F A van de Loo
Journal:  Clin Exp Rheumatol       Date:  1999 Nov-Dec       Impact factor: 4.473

Review 3.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.

Authors:  E K Park; H S Jung; H I Yang; M C Yoo; C Kim; K S Kim
Journal:  Inflamm Res       Date:  2007-01       Impact factor: 4.575

Review 5.  Macrophages in rheumatoid arthritis.

Authors:  N Maruotti; F P Cantatore; E Crivellato; A Vacca; D Ribatti
Journal:  Histol Histopathol       Date:  2007-05       Impact factor: 2.303

Review 6.  TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.

Authors:  T R Mikuls; L W Moreland
Journal:  Expert Opin Pharmacother       Date:  2001-01       Impact factor: 3.889

7.  Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.

Authors:  A M Malfait; G Verbruggen; E M Veys; J Lambert; L De Ridder; M Cornelissen
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

Review 8.  Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).

Authors:  P Conti; P Youinou; T C Theoharides
Journal:  Autoimmun Rev       Date:  2006-10-16       Impact factor: 9.754

9.  Synovial tissue macrophage populations and articular damage in rheumatoid arthritis.

Authors:  D Mulherin; O Fitzgerald; B Bresnihan
Journal:  Arthritis Rheum       Date:  1996-01

10.  Taurine chloramine differentially inhibits matrix metalloproteinase 1 and 13 synthesis in interleukin-1beta stimulated fibroblast-like synoviocytes.

Authors:  Kyoung Soo Kim; Eun Kyung Park; Seung Min Ju; Hye-Sook Jung; Jun Soo Bang; Chaekyun Kim; Yeon-Ah Lee; Seung-Jae Hong; Sang-Hoon Lee; Hyung-In Yang; Myung Chul Yoo
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  14 in total

1.  Intravenous anesthetic ketamine attenuates complete Freund's adjuvant-induced arthritis in rats via modulation of MAPKs/NF-κB.

Authors:  Hui Lin; Zhe Wang; Jinmei Shen; Junmei Xu; Hui Li
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

2.  Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-κB in human osteoarthritis chondrocytes.

Authors:  Zafar Rasheed; Nahid Akhtar; Tariq M Haqqi
Journal:  Rheumatology (Oxford)       Date:  2010-12-20       Impact factor: 7.580

3.  Mutual effect between neuropeptides and inflammatory cytokines in neurogenic SMSCs of human temporomandibular joint.

Authors:  Zhi-Ming Liu; You-Jian Peng; Xing Long; Jian Li; Jin Ke; Wei Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

4.  miR-573 is a negative regulator in the pathogenesis of rheumatoid arthritis.

Authors:  Lin Wang; Guanhua Song; Yabing Zheng; Dan Wang; Hongyan Dong; Jihong Pan; Xiaotian Chang
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

5.  BELFAST nonagenarians: nature or nurture? Immunological, cardiovascular and genetic factors.

Authors:  I M Rea
Journal:  Immun Ageing       Date:  2010-05-27       Impact factor: 6.400

6.  Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.

Authors:  Nagaraja Haleagrahara; Kelly Hodgson; Socorro Miranda-Hernandez; Samuel Hughes; Anupama Bangra Kulur; Natkunam Ketheesan
Journal:  Inflammopharmacology       Date:  2018-04-03       Impact factor: 4.473

7.  Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes.

Authors:  Yeon-Ah Lee; Hyun Mi Choi; Sang-Hoon Lee; Hyung-In Yang; Myung Chul Yoo; Seung-Jae Hong; Kyoung Soo Kim
Journal:  Exp Mol Med       Date:  2012-07-31       Impact factor: 8.718

8.  WIN-34B May Have Analgesic and Anti-Inflammatory Effects by Reducing the Production of Pro-Inflammatory Mediators in Cells via Inhibition of IκB Signaling Pathways.

Authors:  Kyoung Soo Kim; Hyun Mi Choi; Hyung-In Yang; Myung Chul Yoo
Journal:  Biomol Ther (Seoul)       Date:  2012-01       Impact factor: 4.634

9.  TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.

Authors:  Asuka Inoue; Isao Matsumoto; Yuki Tanaka; Naoto Umeda; Chinatsu Takai; Hoshimi Kawaguchi; Hiroshi Ebe; Hiroto Yoshida; Yoshihiro Matsumoto; Seiji Segawa; Satoru Takahashi; Takayuki Sumida
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

10.  Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xianjin Zhu; Lianbo Xiao; Rongfen Huo; Jie Zhang; Jinpiao Lin; Jun Xie; Songtao Sun; Yong He; Yue Sun; Zhou Zhou; Baihua Shen; Ningli Li
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.